Dan Chung


Dr. Chung was appointed Chief Medical Officer of SparingVision in February 2021. In his role, he leads the clinical development and research into SPVN06, SparingVision’s flagship development asset, and is responsible for the clinical development of current and future pipeline products. Dr. Chung also leads the education of the medical community ...


Roles at SparingVision

  • CMO

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.